Clinical Trial Update: SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA [Phase 4]

View source ↗

Summary

Sirtex Medical conducted a Phase 4 trial to calculate the radiation-absorbed dose of 99mTc-MAA used in planning SIR-Spheres Y-90 microsphere therapy for liver c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Neoplasm

Drugs mentioned

• SIR-Spheres (yttrium-90 glass microspheres)

Snippet

Sponsor: Sirtex Medical | Conditions: Carcinoma, Carcinoma, Hepatocellular | Phase 4 | Status: COMPLETED | Results posted: 2025-01-29